Changes in Hemoglobin Level Distribution in US Dialysis Patients From June 2006 to November 2008

American Journal of Kidney Diseases

Volumn 55, Issue 1, 2010, Pages 113-120

  Spiegel, David M ^a   Khan, Irfan ^b   Krishnan, Mahesh ^b   Mayne, Tracy J ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b AMGEN INC   (United States)

Author keywords

dialysis; erythropoiesis stimulating agents; Hb standard deviation; Hemoglobin (Hb) distribution

Indexed keywords

ANTIANEMIC AGENT; HEMOGLOBIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; ARTICLE; DRUG USE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; RETROSPECTIVE STUDY; UNITED STATES;

ANEMIA; FOLLOW-UP STUDIES; HEMOGLOBINS; HUMANS; KIDNEY FAILURE, CHRONIC; PREVALENCE; PROGNOSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; TIME FACTORS; UNITED STATES;

EID: 71849114324     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.09.024     Document Type: Article

References (27)

1. Collins A.J., Li S., St. Peter W., et al. Death, hospitalization, and economic associations among incident hemodialysis patients with hematocrit values of 36 to 39%. J Am Soc Nephrol 12 (2001) 2465-2473
2. Foley R.N., Parfrey P.S., Harnett J.D., Kent G.M., Murray D.C., and Barre P.E. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 28 (1996) 53-61
3. Lowrie E.G., Huang W.H., Lew N.L., and Liu Y. The relative contribution of measured variables to death risk among hemodialysis patients. In: Hingman F.E. (Ed). Death on Hemodialysis: Preventable or Inevitable (1994), Kluwer Academic Publishers, Boston, MA 121-141
4. Ma J.Z., Ebben J., Xia H., and Collins A.J. Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 10 (1999) 610-619
5. Ofsthun N., Labrecque J., Lacson E., Keen M., and Lazarus J.M. The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients. Kidney Int 63 (2003) 1908-1914
6. Regidor D.L., Kopple J.D., Kovesdy C.P., et al. Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol 17 (2006) 1181-1191
7. Roberts T.L., Foley R.N., Weinhandl E.D., Gilbertson D.T., and Collins A.J. Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels. Nephrol Dial Transplant 21 (2006) 1652-1662
8. Eschbach J.W., Abdulhadi M.H., Browne J.K., et al. Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trial. Ann Intern Med 111 (1989) 992-1000
9. Eschbach J.W., Egrie J.C., Downing M.R., Browne J.K., and Adamson J.W. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial. N Engl J Med 316 (1987) 73-78
10. Canadian Erythropoietin Study Group. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. BMJ 300 (1990) 573-578
11. Beusterien K.M., Nissenson A.R., Port F.K., Kelly M., Steinwald B., and Ware Jr. J.E. The effects of recombinant human erythropoietin on functional health and well-being in chronic dialysis patients. J Am Soc Nephrol 7 (1996) 763-773
12. Evans R.W., Manninen D.L., Garrison Jr. L.P., et al. The quality of life of patients with end-stage renal disease. N Engl J Med 312 (1985) 553-559
13. Evans R.W., Rader B., and Manninen D.L. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group. JAMA 263 (1990) 825-830
14. Laupacis A. Changes in quality of life and functional capacity in hemodialysis patients treated with recombinant human erythropoietin. The Canadian Erythropoietin Study Group. Semin Nephrol 10 (1990) 11-19
15. National Kidney Foundation. DOQI Clinical Practice Guidelines for the Treatment of Anemia of Chronic Renal Failure. Am J Kidney Dis 30 suppl 3 (1997) S192-S240
16. US Renal Data System. USRDS 2008 Annual Data Report (2008), The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
17. Singh A.K., Szczech L., Tang K.L., et al. Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355 (2006) 2085-2098
18. Drueke T.B., Locatelli F., Clyne N., et al. Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355 (2006) 2071-2084
19. Besarab A., Bolton W.K., Browne J.K., et al. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin. N Engl J Med 339 (1998) 584-590
20. Epogen (epoetin alfa) [prescribing information] (2008), Amgen Inc, Thousand Oaks, CA
21. Aranesp (darbepoetin alfa) [prescribing information] (2008), Amgen Inc, Thousand Oaks, CA
22. National Kidney Foundation. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 update of hemoglobin target. Am J Kidney Dis 50 (2007) 471-530
23. Centers for Medicare & Medicaid Services. CMS Manual System. Pub 100-04 Medicare Claims Processing. Transmittal 1307. http://www.cms.hhs.gov/Transmittals/Downloads/R1307CP.pdf Accessed January 15, 2009
24. Lacson Jr. E., Ofsthun N., and Lazarus J.M. Effect of variability in anemia management on hemoglobin outcomes in ESRD. Am J Kidney Dis 41 (2003) 111-124
25. Chan K., Moran J., Hlatky M., and Lafayette R. Protocol adherence and the ability to achieve target haemoglobin levels in haemodialysis patients. Nephrol Dial Transplant 24 (2009) 1956-1962
26. Spiegel D.M., Gitlin M., and Mayne T. Factors affecting anemia management in hemodialysis patients: a single-center experience. Hemodial Int 12 (2008) 336-341
27. Weiner D.E., Miskulin D.C., Seefeld K., et al. Reducing versus discontinuing erythropoietin at high hemoglobin levels. J Am Soc Nephrol 18 (2007) 3184-3191